
Midatech Pharma plc MTP
Geschäftsbericht 2024
hinzugefügt 07.02.2026
Midatech Pharma plc Gesamtes Eigenkapital 2011-2026 | MTP
Gesamtes Eigenkapital Jährlich Midatech Pharma plc
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 6.72 M | 19.6 M | 16.9 M | 34.7 M | 45.7 M | 46.9 M | - | - | - | - |
Alle Zahlen in GBP-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 46.9 M | 6.72 M | 28.4 M |
Gesamtes Eigenkapital Vierteljährlich Midatech Pharma plc
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 10.5 M | - | - | - | 6.72 M | - | - | - | 19.6 M | - | - | - | 16.9 M | - | - | - | 34.7 M | - | - | - | 45.7 M | - | - | - | 46.9 M | - | - | - | 42 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in GBP-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 46.9 M | 6.72 M | 27.9 M |
Gesamtes Eigenkapital anderer Aktien in der Pharmaeinzelhändler
| Name | Gesamtes Eigenkapital | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Alnylam Pharmaceuticals
ALNY
|
67.1 M | $ 322.7 | 0.84 % | $ 41.2 B | ||
|
Acer Therapeutics
ACER
|
-16.8 M | - | 2.71 % | $ 14 M | ||
|
MorphoSys AG
MOR
|
621 M | - | 2.43 % | $ 254 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
39.5 M | - | -15.15 % | $ 60.3 M | ||
|
Adverum Biotechnologies
ADVM
|
70.7 M | - | - | $ 86.2 M | ||
|
Amarin Corporation plc
AMRN
|
552 M | $ 15.14 | 2.61 % | $ 6.17 B | ||
|
Acasti Pharma
ACST
|
66.6 M | - | 4.01 % | $ 150 M | ||
|
I-Mab
IMAB
|
1.72 B | - | - | $ 866 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
29.5 M | - | - | $ 26.5 M | ||
|
Aptorum Group Limited
APM
|
21.1 M | $ 0.84 | 2.78 % | $ 4.58 M | ||
|
Adagene
ADAG
|
50.5 M | $ 2.95 | 10.57 % | $ 166 M | ||
|
Biophytis SA
BPTS
|
2.27 M | - | -13.47 % | $ 169 M | ||
|
AlloVir
ALVR
|
113 M | - | 4.14 % | $ 49.1 M | ||
|
Ampio Pharmaceuticals
AMPE
|
3.36 M | - | -11.43 % | $ 502 K | ||
|
Alterity Therapeutics Limited
ATHE
|
35.5 M | $ 3.51 | -1.68 % | $ 8.45 B | ||
|
BioNTech SE
BNTX
|
1.37 B | $ 110.14 | -0.18 % | $ 27.2 B | ||
|
Applied Molecular Transport
AMTI
|
60.8 M | - | - | $ 10.1 M | ||
|
ARCA biopharma
ABIO
|
382 M | - | 1052.0 % | $ 415 M | ||
|
Cabaletta Bio
CABA
|
236 M | $ 2.62 | 7.38 % | $ 3.06 M | ||
|
Acorda Therapeutics
ACOR
|
-158 M | - | -24.86 % | $ 820 K | ||
|
Compugen Ltd.
CGEN
|
54.9 M | $ 1.79 | 4.39 % | $ 160 M | ||
|
Akero Therapeutics
AKRO
|
750 M | - | - | $ 3.67 B | ||
|
Aeglea BioTherapeutics
AGLE
|
518 M | - | - | $ 1.01 B | ||
|
Aptose Biosciences
APTO
|
-4.54 M | - | -45.71 % | $ 1.2 M | ||
|
Albireo Pharma
ALBO
|
176 M | - | -0.23 % | $ 916 M | ||
|
Ascendis Pharma A/S
ASND
|
884 M | $ 222.04 | - | $ 5 B | ||
|
Allena Pharmaceuticals
ALNA
|
18.9 M | - | 3.16 % | $ 1.9 M | ||
|
Aptinyx
APTX
|
38.3 M | - | -39.0 % | $ 4.57 M | ||
|
Aravive
ARAV
|
10.7 M | - | -13.39 % | $ 1.45 M | ||
|
Corcept Therapeutics Incorporated
CORT
|
680 M | $ 41.27 | -0.1 % | $ 4.26 B | ||
|
Catalyst Pharmaceuticals
CPRX
|
728 M | $ 24.19 | -1.06 % | $ 2.87 B | ||
|
Arena Pharmaceuticals
ARNA
|
673 M | - | -6.81 % | $ 3.04 B | ||
|
Champions Oncology
CSBR
|
3.77 M | $ 6.41 | -2.14 % | $ 87.6 M | ||
|
Burford Capital Limited
BUR
|
1.7 B | $ 9.18 | 2.34 % | $ 1.48 B | ||
|
Aridis Pharmaceuticals
ARDS
|
-24.2 M | - | 17.91 % | $ 11.1 M | ||
|
AgeX Therapeutics
AGE
|
5.47 M | - | -10.17 % | $ 12.2 K | ||
|
Athira Pharma
ATHA
|
44.8 M | - | - | $ 269 M | ||
|
Athersys
ATHX
|
16.4 M | - | 3.77 % | $ 22.4 M | ||
|
Akouos
AKUS
|
234 M | - | 0.23 % | $ 488 M | ||
|
Avenue Therapeutics
ATXI
|
2.8 M | - | -52.27 % | $ 4.45 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
5.44 M | $ 4.54 | 7.58 % | $ 9.88 B | ||
|
Precision BioSciences
DTIL
|
18.9 M | $ 3.77 | -1.05 % | $ 14.5 M | ||
|
Autolus Therapeutics plc
AUTL
|
427 M | $ 1.46 | -0.34 % | $ 373 M | ||
|
Amneal Pharmaceuticals
AMRX
|
-109 M | $ 14.73 | 1.41 % | $ 4.55 B | ||
|
Codexis
CDXS
|
66.9 M | $ 1.27 | -1.55 % | $ 93.2 M |